Molecular Engineering of Erythrotropic Bacteria for Treatment and Prevention of Human Malaria
Investigator: Joseph Derisi, PhD
Sponsor: Bill & Melinda Gates Foundation
Location(s): United States
Joseph DeRisi of the University of California at San Francisco proposes to engineer naturally occurring erythrotropic bacteria to target malaria infected red blood cells to serve as a potential prophylactic and treatment for malaria in humans.